Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Neurodegenerative Diseases: World Drug Market 2011-2026

Neurodegenerative Diseases: World Drug Market 2011-2026 - new market research report published


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2012-12-11 12:20:17 - Neurodegenerative Diseases: World Drug Market 2011-2026 - a new market research report on companiesandmarkets.com

Would you like to know how the industry and market for neurodegenerative drug treatments will develop? There will be trends to watch from 2010 onwards, especially areas of revenue growth. You can have our new report now, staying ahead, saving time and aiding your decisions.The number of patients may quadruple worldwide by 2050. Yet, there remain significant unmet needs in all sectors of the neurodegenerative treatments market.You can assess those commercial opportunities now, with us providing forecasts for the following drug markets from 2010 to 2026:• Multiple sclerosis
• Alzheimer´s disease
• Parkinson´s disease
• Neuropathies
• Huntington´s disease
• Amyotrophic lateral sclerosis.Our new report analyses and discusses strengths, weaknesses and revenue trends of the sector from 2009 to 2026.All sectors of the market have

 

 

been expanding, but which will fare best from 2010 onwards? How will those submarkets, and the overall market sector, cope with patent expiries this decade? How will leading national markets perform from 2010 to 2026? What opportunities are there for resolving unmet therapeutic needs?We show you where the neurodegenerative drug treatment sector is heading. Our report shows you its technological and commercial potential, revealing opportunities, challenges and requirements for success there.New drugs with improved safety and efficacy can gain significant market shares from 2010 onwards. There remain high revenues to be made in this sector from 2010 to 2026, as we show and explain. New treatment types - such as oral agents for MS - could re-shape the market from this decade onwards. There will be commercial growth, with important trends to watch.This Visiongain report shows how you could make gains there. Our report makes it quick and practical for you to assess the potential of the industry and market now. Our new report provides you with revenue forecasts, market share analyses, R&D pipeline developments and expert opinion. That way, you can assess prospects, opportunities and threats in the sector. It is that combination of data that sets us apart.We include 98 tables and figures and two expert interviews (shown in the accompanying lists). You can stay ahead by ordering our report today, benefiting your analyses and commercial ideas. World Neurodegenerative Diseases: World Drug Market 2011-2026 shows you revenue trends, opportunities and challengesOur report gives you the following advantages:• You will receive hard data for the neurodegenerative diseases sector - especially our revenue forecasts - helping you to stay ahead
• You will discover revenue trends for the overall market and its main components from 2009 to 2026 - showing you where commercial potential will lie
• You will find revenue predictions for leading national markets from 2009 to 2026 (US, Japan, UK, Germany, France, Spain, Italy, China and India)
• You will learn how the sector can change and adapt from 2010 to 2026
• You will assess leading organisations in neurodegenerative disease treatment, discovering their activities and prospects
• You will discover the drivers, restraints, competition and opportunities influencing this sector, including oral agents for MS, outcomes of research and drug targets
• You will investigate unmet and under-met needs in that sector, with therapeutic requirements and commercial opportunities discussed
• You will review R&D pipelines, assessing the potential of developments
• You will view expert opinion from our survey, including interview transcripts
• You will find out where the sector is heading - technology, competition, revenues and other aspects of the industry and market.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com